Professor Fiona Carragher, Chief Policy and Research Officer at Alzheimer’s Society, comments on the Chancellor's Autumn ...

Semaglutide (the essential ingredient in Rybelsus, Ozempic and Wegovy) is currently in the headlines after the disappointing ...

A new study, funded by Alzheimer’s Society, has identified three existing medications that could be repurposed to treat or prevent Alzheimer’s disease.

One in five people affected by dementia have received no health care, social care or financial support, our new in-depth report has found. One in five people affected by dementia have received no ...

It can be difficult to know what to say to the person you care for. Telling the truth can cause the person with dementia to have an emotional response and, in some cases, may make things worse. Not ...

NICE says that donanemab and lecanemab, the first disease-modifying treatments for early Alzheimer’s disease, should not be provided on the NHS. On Thursday, 19 June, the National Institute for Health ...

As one in three people living with dementia in the UK remain undiagnosed, we highlight the six key symptoms to look out for. During Dementia Action Week we are shining a light on the six most common ...

At Alzheimer’s Society, we're now a proud partner in a £6 million initiative funded by UK Research and Innovation (UKRI) and the National Institute for Health and Care Research (NIHR) to develop ...

A healthy sleep routine can help the person with dementia to feel better, be less confused, be more co-ordinated and have more energy in the daytime. These tips for how to support them to sleep better ...

The issues faced by someone with young-onset dementia will be very different to those experienced by someone older. This page includes information on talking to children about a diagnosis, driving and ...

Today the dementia diagnosis rate target (that 66.7% of people living with dementia in England should have a diagnosis) has been removed from the NHS Operational Planning Guidance for 2025-6. Fiona ...

A nationwide clinical trial aiming to revolutionise how dementia is diagnosed is now underway. Research teams will assess how blood tests could be used to detect dementia at various stages. The Blood ...